- India holds major stakes in the ongoing negotiations for the WHO Global Pandemic Agreement, balancing global health security with domestic industrial interests. - Key contentious issues include equitable access to pathogen genetic sequence data (PABS), benefit-sharing, and technology/know-how transfer for vaccines and therapeutics. - Intellectual Property Rights (IPR) flexibilities and protection of India's robust generic pharmaceutical manufacturing capacity are critical negotiating priorities. - A balanced agreement must avoid imposing disproportionate burdens on developing nations while ensuring rapid response capabilities against future health emergencies. - **Global Pandemic Agreement:** A legally binding instrument currently negotiated under the World Health Organization to strengthen global prevention, preparedness, and response to future pandemics, focusing on equity and access to countermeasures. - **TRIPS Agreement:** A WTO international agreement administering intellectual property standards, key to debates over compulsory licensing and technology transfer for generic drug manufacturing during public health crises. - **World Health Organization:** The specialized agency of the United Nations responsible for international public health, coordinating responses to health emergencies and setting global norms. **Introduction** The article discusses India's strategic stakes in the World Health Organization's (WHO) Global Pandemic Agreement negotiations. It highlights the tension between global health equity, pathogen sharing, intellectual property rights, and the protection of India's domestic pharmaceutical and generic manufacturing ecosystem. **Core Issue and Detailed Points** - India holds major stakes in the ongoing negotiations for the WHO Global Pandemic Agreement, balancing global health security with domestic industrial interests. - Key contentious issues include equitable access to pathogen genetic sequence data (PABS), benefit-sharing, and technology/know-how transfer for vaccines and therapeutics. - Intellectual Property Rights (IPR) flexibilities and protection of India's robust generic pharmaceutical manufacturing capacity are critical negotiating priorities. - A balanced agreement must avoid imposing disproportionate burdens on developing nations while ensuring rapid response capabilities against future health emergencies. **Key Statutory Bodies, Acts & Concepts** - **Global Pandemic Agreement:** A legally binding instrument currently negotiated under the World Health Organization to strengthen global prevention, preparedness, and response to future pandemics, focusing on equity and access to countermeasures. - **TRIPS Agreement:** A WTO international agreement administering intellectual property standards, key to debates over compulsory licensing and technology transfer for generic drug manufacturing during public health crises. - **World Health Organization:** The specialized agency of the United Nations responsible for international public health, coordinating responses to health emergencies and setting global norms.